Fresenius Medical Care AG, founded in 1996 and headquartered in Bad Homburg, Germany, is a leading provider of products and services for individuals undergoing dialysis due to chronic kidney failure. The company specializes in the manufacturing of dialysis machines, as well as providing comprehensive dialysis services globally through a vast network of outpatient clinics.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| FMEGR 0.63% 2026-11-30 EURFresenius Medical Care AG | Germany | 2026-11-30 | 0.625 | 2.35 |
| FMEGR 1.00% 2026-05-29 EURFresenius Medical Care AG | Germany | 2026-05-29 | 1.000 | 2.29 |
| FMEGR 1.25% 2029-11-29 EURFresenius Medical Care AG | Germany | 2029-11-29 | 1.250 | 2.87 |
| FMEGR 1.50% 2025-07-11 EURFresenius Medical Care AG | Germany | 2025-07-11 | 1.500 | 0.00 |
| FMEGR 1.50% 2030-05-29 EURFresenius Medical Care AG | Germany | 2030-05-29 | 1.500 | 3.02 |
| FMEGR 3.13% 2028-12-08 EURFresenius Medical Care AG | Germany | 2028-12-08 | 3.125 | 2.73 |
| FMEGR 3.25% 2030-11-24 EURFresenius Medical Care AG | Germany | 2030-11-24 | 3.250 | 3.09 |
| FMEGR 3.75% 2032-04-08 EURFresenius Medical Care AG | Germany | 2032-04-08 | 3.750 | 3.35 |
| FMEGR 3.88% 2027-09-20 EURFresenius Medical Care AG | Germany | 2027-09-20 | 3.875 | 2.58 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Fresenius Medical Care AG first began issuing bonds in 2004, enhancing its financial flexibility for expansion and acquisition. Notably, in 2020, the company issued €500 million in senior unsecured bonds yielding approximately 2.2%, which was leveraged to bolster its capital amid the COVID-19 pandemic. Currently, Fresenius bonds are regarded for their relative stability and competitive yields compared to the healthcare sector, underscoring the company's robust credit profile despite industry challenges.